APO Research
Talk to an analyst

APO RESEARCH · REPORT

Neuroprotective Agents

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Neuroprotective Agents Industry Growth and Trends Forecast to 2032

22 December 202590 pages

Choose your research edition.

Industry ResearchNeuroprotective Agents Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Neuroprotective Agents Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Neuroprotective Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neuroprotective Agents Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Neuroprotective Agents Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Neuroprotective Agents market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Neuroprotective Agents is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Neuroprotective Agents is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Neuroprotective Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Neuroprotective Agents include Allon Therapeutics, Ceregene, Genervon Biopharmaceuticals, Neuren Pharmaceuticals and NeuroVive Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Neuroprotective Agents market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Neuroprotective Agents market size, estimates, and forecasts are presented in terms of sales volume (k tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Neuroprotective Agents market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Neuroprotective Agents.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Neuroprotective Agents market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Neuroprotective Agents Market by Company

Allon Therapeutics

Ceregene

Genervon Biopharmaceuticals

Neuren Pharmaceuticals

NeuroVive Pharmaceutical

Neuroprotective Agents Segment by Type

Ophthalmic Diseases

Neurodegenerative Disorders

Cerebrovascular Diseases

Traumatic CNS Injuries

Neuroprotective Agents Segment by Application

Hospitals

Clinics

Others

Neuroprotective Agents Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neuroprotective Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neuroprotective Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neuroprotective Agents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Neuroprotective Agents manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Neuroprotective Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Ophthalmic Diseases Table 2. Major Company of Neurodegenerative Disorders Table 3. Major Company of Cerebrovascular Diseases Table 4. Major Company of Traumatic CNS Injuries Table 5. Global Neuroprotective Agents Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Neuroprotective Agents Sales by Type (2021-2026) & (k tons) Table 7. Global Neuroprotective Agents Sales Market Share in Volume by Type (2021-2026) Table 8. Global Neuroprotective Agents Sales by Type (2021-2026) & (US$ Million) Table 9. Global Neuroprotective Agents Sales Market Share in Value by Type (2021-2026) Table 10. Global Neuroprotective Agents Price by Type (2021-2026) & (US$/ton) Table 11. Global Neuroprotective Agents Sales by Type (2027-2032) & (k tons) Table 12. Global Neuroprotective Agents Sales Market Share in Volume by Type (2027-2032) Table 13. Global Neuroprotective Agents Sales by Type (2027-2032) & (US$ Million) Table 14. Global Neuroprotective Agents Sales Market Share in Value by Type (2027-2032) Table 15. Global Neuroprotective Agents Price by Type (2027-2032) & (US$/ton) Table 16. North America Neuroprotective Agents Sales by Type (2021-2026) & (k tons) Table 17. North America Neuroprotective Agents Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Neuroprotective Agents Sales by Type (2021-2026) & (k tons) Table 19. Europe Neuroprotective Agents Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Neuroprotective Agents Sales by Type (2021-2026) & (k tons) Table 21. Asia-Pacific Neuroprotective Agents Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Neuroprotective Agents Sales by Type (2021-2026) & (k tons) Table 23. Latin America Neuroprotective Agents Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Neuroprotective Agents Sales by Type (2021-2026) & (k tons) Table 25. Middle East and Africa Neuroprotective Agents Sales by Type (2021-2026) & (US$ Million) Table 26. Neuroprotective Agents Industry Trends Table 27. Neuroprotective Agents Industry Drivers Table 28. Neuroprotective Agents Industry Opportunities and Challenges Table 29. Neuroprotective Agents Industry Restraints Table 30. Global Neuroprotective Agents Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Neuroprotective Agents Revenue Market Share by Company (2021-2026) Table 32. Global Neuroprotective Agents Sales by Company (2021-2026) & (k tons) Table 33. Global Neuroprotective Agents Sales Share by Company (2021-2026) Table 34. Global Neuroprotective Agents Market Price by Company (2021-2026) & (US$/ton) Table 35. Global Neuroprotective Agents Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Neuroprotective Agents Major Company Production Sites and Headquarters Table 37. Global Neuroprotective Agents Company, Product Type & Application Table 38. Global Neuroprotective Agents Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Neuroprotective Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Neuroprotective Agents Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Neuroprotective Agents Sales by Region (2021-2026) & (k tons) Table 43. Global Neuroprotective Agents Sales Market Share in Volume by Region (2021-2026) Table 44. Global Neuroprotective Agents Sales by Region (2021-2026) & (US$ Million) Table 45. Global Neuroprotective Agents Sales Market Share in Value by Region (2021-2026) Table 46. Global Neuroprotective Agents Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 47. Global Neuroprotective Agents Sales by Region (2027-2032) & (k tons) Table 48. Global Neuroprotective Agents Sales Market Share in Volume by Region (2027-2032) Table 49. Global Neuroprotective Agents Sales by Region (2027-2032) & (US$ Million) Table 50. Global Neuroprotective Agents Sales Market Share in Value by Region (2027-2032) Table 51. Global Neuroprotective Agents Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2027-2032) Table 52. Global Neuroprotective Agents Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Neuroprotective Agents Sales by Application (2021-2026) & (k tons) Table 54. Global Neuroprotective Agents Sales Market Share in Volume by Application (2021-2026) Table 55. Global Neuroprotective Agents Sales by Application (2021-2026) & (US$ Million) Table 56. Global Neuroprotective Agents Sales Market Share in Value by Application (2021-2026) Table 57. Global Neuroprotective Agents Price by Application (2021-2026) & (US$/ton) Table 58. Global Neuroprotective Agents Sales by Application (2027-2032) & (k tons) Table 59. Global Neuroprotective Agents Sales Market Share in Volume by Application (2027-2032) Table 60. Global Neuroprotective Agents Sales by Application (2027-2032) & (US$ Million) Table 61. Global Neuroprotective Agents Sales Market Share in Value by Application (2027-2032) Table 62. Global Neuroprotective Agents Price by Application (2027-2032) & (US$/ton) Table 63. North America Neuroprotective Agents Sales by Application (2021-2026) & (k tons) Table 64. North America Neuroprotective Agents Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Neuroprotective Agents Sales by Application (2021-2026) & (k tons) Table 66. Europe Neuroprotective Agents Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Neuroprotective Agents Sales by Application (2021-2026) & (k tons) Table 68. Asia-Pacific Neuroprotective Agents Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Neuroprotective Agents Sales by Application (2021-2026) & (k tons) Table 70. Latin America Neuroprotective Agents Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Neuroprotective Agents Sales by Application (2021-2026) & (k tons) Table 72. Middle East and Africa Neuroprotective Agents Sales by Application (2021-2026) & (US$ Million) Table 73. Allon Therapeutics Company Information Table 74. Allon Therapeutics Business Overview Table 75. Allon Therapeutics Neuroprotective Agents Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 76. Allon Therapeutics Neuroprotective Agents Product Portfolio Table 77. Allon Therapeutics Recent Development Table 78. Ceregene Company Information Table 79. Ceregene Business Overview Table 80. Ceregene Neuroprotective Agents Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 81. Ceregene Neuroprotective Agents Product Portfolio Table 82. Ceregene Recent Development Table 83. Genervon Biopharmaceuticals Company Information Table 84. Genervon Biopharmaceuticals Business Overview Table 85. Genervon Biopharmaceuticals Neuroprotective Agents Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 86. Genervon Biopharmaceuticals Neuroprotective Agents Product Portfolio Table 87. Genervon Biopharmaceuticals Recent Development Table 88. Neuren Pharmaceuticals Company Information Table 89. Neuren Pharmaceuticals Business Overview Table 90. Neuren Pharmaceuticals Neuroprotective Agents Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 91. Neuren Pharmaceuticals Neuroprotective Agents Product Portfolio Table 92. Neuren Pharmaceuticals Recent Development Table 93. NeuroVive Pharmaceutical Company Information Table 94. NeuroVive Pharmaceutical Business Overview Table 95. NeuroVive Pharmaceutical Neuroprotective Agents Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 96. NeuroVive Pharmaceutical Neuroprotective Agents Product Portfolio Table 97. NeuroVive Pharmaceutical Recent Development Table 98. North America Neuroprotective Agents Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 99. North America Neuroprotective Agents Sales by Country (2021-2026) & (k tons) Table 100. North America Neuroprotective Agents Sales Market Share by Country (2021-2026) Table 101. North America Neuroprotective Agents Sales Forecast by Country (2027-2032) & (k tons) Table 102. North America Neuroprotective Agents Sales Market Share Forecast by Country (2027-2032) Table 103. North America Neuroprotective Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. North America Neuroprotective Agents Market Size by Country (2021-2026) & (US$ Million) Table 105. North America Neuroprotective Agents Market Share by Country (2021-2026) Table 106. North America Neuroprotective Agents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. North America Neuroprotective Agents Market Share Forecast by Country (2027-2032) Table 108. Europe Neuroprotective Agents Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 109. Europe Neuroprotective Agents Sales by Country (2021-2026) & (k tons) Table 110. Europe Neuroprotective Agents Sales Market Share by Country (2021-2026) Table 111. Europe Neuroprotective Agents Sales Forecast by Country (2027-2032) & (k tons) Table 112. Europe Neuroprotective Agents Sales Market Share Forecast by Country (2027-2032) Table 113. Europe Neuroprotective Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Europe Neuroprotective Agents Market Size by Country (2021-2026) & (US$ Million) Table 115. Europe Neuroprotective Agents Market Share by Country (2021-2026) Table 116. Europe Neuroprotective Agents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Europe Neuroprotective Agents Market Share Forecast by Country (2027-2032) Table 118. Asia-Pacific Neuroprotective Agents Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 119. Asia-Pacific Neuroprotective Agents Sales by Country (2021-2026) & (k tons) Table 120. Asia-Pacific Neuroprotective Agents Sales Market Share by Country (2021-2026) Table 121. Asia-Pacific Neuroprotective Agents Sales Forecast by Country (2027-2032) & (k tons) Table 122. Asia-Pacific Neuroprotective Agents Sales Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific Neuroprotective Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific Neuroprotective Agents Market Size by Country (2021-2026) & (US$ Million) Table 125. Asia-Pacific Neuroprotective Agents Market Share by Country (2021-2026) Table 126. Asia-Pacific Neuroprotective Agents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Asia-Pacific Neuroprotective Agents Market Share Forecast by Country (2027-2032) Table 128. Latin America Neuroprotective Agents Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 129. Latin America Neuroprotective Agents Sales by Country (2021-2026) & (k tons) Table 130. Latin America Neuroprotective Agents Sales Market Share by Country (2021-2026) Table 131. Latin America Neuroprotective Agents Sales Forecast by Country (2027-2032) & (k tons) Table 132. Latin America Neuroprotective Agents Sales Market Share Forecast by Country (2027-2032) Table 133. Latin America Neuroprotective Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Latin America Neuroprotective Agents Market Size by Country (2021-2026) & (US$ Million) Table 135. Latin America Neuroprotective Agents Market Share by Country (2021-2026) Table 136. Latin America Neuroprotective Agents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Latin America Neuroprotective Agents Market Share Forecast by Country (2027-2032) Table 138. Middle East and Africa Neuroprotective Agents Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 139. Middle East and Africa Neuroprotective Agents Sales by Country (2021-2026) & (k tons) Table 140. Middle East and Africa Neuroprotective Agents Sales Market Share by Country (2021-2026) Table 141. Middle East and Africa Neuroprotective Agents Sales Forecast by Country (2027-2032) & (k tons) Table 142. Middle East and Africa Neuroprotective Agents Sales Market Share Forecast by Country (2027-2032) Table 143. Middle East and Africa Neuroprotective Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East and Africa Neuroprotective Agents Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East and Africa Neuroprotective Agents Market Share by Country (2021-2026) Table 146. Middle East and Africa Neuroprotective Agents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East and Africa Neuroprotective Agents Market Share Forecast by Country (2027-2032) Table 148. Key Raw Materials Table 149. Raw Materials Key Suppliers Table 150. Neuroprotective Agents Distributors List Table 151. Neuroprotective Agents Customers List Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Neuroprotective Agents Image Figure 2. Global Neuroprotective Agents Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neuroprotective Agents Market Size (2021-2032) & (US$ Million) Figure 4. Global Neuroprotective Agents Sales (2021-2032) & (k tons) Figure 5. Ophthalmic Diseases Image Figure 6. Global Ophthalmic Diseases Sales YoY Growth (2021-2032) & (k tons) Figure 7. Neurodegenerative Disorders Image Figure 8. Global Neurodegenerative Disorders Sales YoY Growth (2021-2032) & (k tons) Figure 9. Cerebrovascular Diseases Image Figure 10. Global Cerebrovascular Diseases Sales YoY Growth (2021-2032) & (k tons) Figure 11. Traumatic CNS Injuries Image Figure 12. Global Traumatic CNS Injuries Sales YoY Growth (2021-2032) & (k tons) Figure 13. Global Neuroprotective Agents Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Neuroprotective Agents Market Share by Type 2025 VS 2032 Figure 15. North America Neuroprotective Agents Sales Market Share in Volume by Type in 2025 Figure 16. North America Neuroprotective Agents Sales Market Share in Value by Type in 2025 Figure 17. Europe Neuroprotective Agents Sales Market Share in Volume by Type in 2025 Figure 18. Europe Neuroprotective Agents Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Neuroprotective Agents Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Neuroprotective Agents Sales Market Share in Value by Type in 2025 Figure 21. Latin America Neuroprotective Agents Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Neuroprotective Agents Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Neuroprotective Agents Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Neuroprotective Agents Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Neuroprotective Agents Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Hospitals Image Figure 28. Global Hospitals Sales YoY Growth (2021-2032) & (k tons) Figure 29. Clinics Image Figure 30. Global Clinics Sales YoY Growth (2021-2032) & (k tons) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (k tons) Figure 33. Global Neuroprotective Agents Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Neuroprotective Agents Market Share by Application 2025 VS 2032 Figure 35. North America Neuroprotective Agents Sales Market Share in Volume by Application in 2025 Figure 36. North America Neuroprotective Agents Sales Market Share in Value by Application in 2025 Figure 37. Europe Neuroprotective Agents Sales Market Share in Volume by Application in 2025 Figure 38. Europe Neuroprotective Agents Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Neuroprotective Agents Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Neuroprotective Agents Sales Market Share in Value by Application in 2025 Figure 41. Latin America Neuroprotective Agents Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Neuroprotective Agents Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Neuroprotective Agents Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Neuroprotective Agents Sales Market Share in Value by Application in 2025 Figure 45. North America Neuroprotective Agents Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 46. North America Neuroprotective Agents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Neuroprotective Agents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Neuroprotective Agents Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Neuroprotective Agents Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 50. Europe Neuroprotective Agents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Neuroprotective Agents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Neuroprotective Agents Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Neuroprotective Agents Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 54. Asia-Pacific Neuroprotective Agents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Neuroprotective Agents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Neuroprotective Agents Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Neuroprotective Agents Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 58. Latin America Neuroprotective Agents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Neuroprotective Agents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Neuroprotective Agents Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Neuroprotective Agents Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 62. Middle East and Africa Neuroprotective Agents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Neuroprotective Agents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Neuroprotective Agents Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Neuroprotective Agents Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Neuroprotective Agents Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Ophthalmic Diseases
  • Neurodegenerative Disorders
  • Cerebrovascular Diseases
  • Traumatic CNS Injuries
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Allon Therapeutics
  • Ceregene
  • Genervon Biopharmaceuticals
  • Neuren Pharmaceuticals
  • NeuroVive Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Neuroprotective Agents Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Neuroprotective Agents Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Neuroprotective Agents Market by Type
  6. 1.3.1 Ophthalmic Diseases
  7. 1.3.2 Neurodegenerative Disorders
  8. 1.3.3 Cerebrovascular Diseases
  9. 1.3.4 Traumatic CNS Injuries
  10. 1.4 Global Neuroprotective Agents Market Size by Type
  11. 1.4.1 Global Neuroprotective Agents Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Neuroprotective Agents Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Neuroprotective Agents Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Neuroprotective Agents Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Neuroprotective Agents Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Neuroprotective Agents Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Neuroprotective Agents Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Neuroprotective Agents Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Neuroprotective Agents Industry Trends
  2. 2.2 Neuroprotective Agents Industry Drivers
  3. 2.3 Neuroprotective Agents Industry Opportunities and Challenges
  4. 2.4 Neuroprotective Agents Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Neuroprotective Agents Revenue (2021-2026)
  2. 3.2 Global Top Players by Neuroprotective Agents Sales (2021-2026)
  3. 3.3 Global Top Players by Neuroprotective Agents Price (2021-2026)
  4. 3.4 Global Neuroprotective Agents Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Neuroprotective Agents Major Company Production Sites & Headquarters
  6. 3.6 Global Neuroprotective Agents Company, Product Type & Application
  7. 3.7 Global Neuroprotective Agents Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Neuroprotective Agents Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Neuroprotective Agents Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Neuroprotective Agents Tier 1, Tier 2, and Tier 3
4 Neuroprotective Agents Regional Status and Outlook
  1. 4.1 Global Neuroprotective Agents Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Neuroprotective Agents Historic Market Size by Region
  3. 4.2.1 Global Neuroprotective Agents Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Neuroprotective Agents Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Neuroprotective Agents Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Neuroprotective Agents Forecasted Market Size by Region
  7. 4.3.1 Global Neuroprotective Agents Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Neuroprotective Agents Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Neuroprotective Agents Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Neuroprotective Agents by Application
  1. 5.1 Neuroprotective Agents Market by Application
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Neuroprotective Agents Market Size by Application
  6. 5.2.1 Global Neuroprotective Agents Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Neuroprotective Agents Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Neuroprotective Agents Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Neuroprotective Agents Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Neuroprotective Agents Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Neuroprotective Agents Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Neuroprotective Agents Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Neuroprotective Agents Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Allon Therapeutics
  2. 6.1.1 Allon Therapeutics Company Information
  3. 6.1.2 Allon Therapeutics Business Overview
  4. 6.1.3 Allon Therapeutics Neuroprotective Agents Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Allon Therapeutics Neuroprotective Agents Product Portfolio
  6. 6.1.5 Allon Therapeutics Recent Developments
  7. 6.2 Ceregene
  8. 6.2.1 Ceregene Company Information
  9. 6.2.2 Ceregene Business Overview
  10. 6.2.3 Ceregene Neuroprotective Agents Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Ceregene Neuroprotective Agents Product Portfolio
  12. 6.2.5 Ceregene Recent Developments
  13. 6.3 Genervon Biopharmaceuticals
  14. 6.3.1 Genervon Biopharmaceuticals Company Information
  15. 6.3.2 Genervon Biopharmaceuticals Business Overview
  16. 6.3.3 Genervon Biopharmaceuticals Neuroprotective Agents Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Genervon Biopharmaceuticals Neuroprotective Agents Product Portfolio
  18. 6.3.5 Genervon Biopharmaceuticals Recent Developments
  19. 6.4 Neuren Pharmaceuticals
  20. 6.4.1 Neuren Pharmaceuticals Company Information
  21. 6.4.2 Neuren Pharmaceuticals Business Overview
  22. 6.4.3 Neuren Pharmaceuticals Neuroprotective Agents Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Neuren Pharmaceuticals Neuroprotective Agents Product Portfolio
  24. 6.4.5 Neuren Pharmaceuticals Recent Developments
  25. 6.5 NeuroVive Pharmaceutical
  26. 6.5.1 NeuroVive Pharmaceutical Company Information
  27. 6.5.2 NeuroVive Pharmaceutical Business Overview
  28. 6.5.3 NeuroVive Pharmaceutical Neuroprotective Agents Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 NeuroVive Pharmaceutical Neuroprotective Agents Product Portfolio
  30. 6.5.5 NeuroVive Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Neuroprotective Agents Sales by Country
  2. 7.1.1 North America Neuroprotective Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Neuroprotective Agents Sales by Country (2021-2026)
  4. 7.1.3 North America Neuroprotective Agents Sales Forecast by Country (2027-2032)
  5. 7.2 North America Neuroprotective Agents Market Size by Country
  6. 7.2.1 North America Neuroprotective Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Neuroprotective Agents Market Size by Country (2021-2026)
  8. 7.2.3 North America Neuroprotective Agents Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Neuroprotective Agents Sales by Country
  2. 8.1.1 Europe Neuroprotective Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Neuroprotective Agents Sales by Country (2021-2026)
  4. 8.1.3 Europe Neuroprotective Agents Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Neuroprotective Agents Market Size by Country
  6. 8.2.1 Europe Neuroprotective Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Neuroprotective Agents Market Size by Country (2021-2026)
  8. 8.2.3 Europe Neuroprotective Agents Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Neuroprotective Agents Sales by Country
  2. 9.1.1 Asia-Pacific Neuroprotective Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Neuroprotective Agents Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Neuroprotective Agents Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Neuroprotective Agents Market Size by Country
  6. 9.2.1 Asia-Pacific Neuroprotective Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Neuroprotective Agents Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Neuroprotective Agents Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Neuroprotective Agents Sales by Country
  2. 10.1.1 South America Neuroprotective Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Neuroprotective Agents Sales by Country (2021-2026)
  4. 10.1.3 South America Neuroprotective Agents Sales Forecast by Country (2027-2032)
  5. 10.2 South America Neuroprotective Agents Market Size by Country
  6. 10.2.1 South America Neuroprotective Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Neuroprotective Agents Market Size by Country (2021-2026)
  8. 10.2.3 South America Neuroprotective Agents Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Neuroprotective Agents Sales by Country
  2. 11.1.1 Middle East and Africa Neuroprotective Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Neuroprotective Agents Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Neuroprotective Agents Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Neuroprotective Agents Market Size by Country
  6. 11.2.1 Middle East and Africa Neuroprotective Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Neuroprotective Agents Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Neuroprotective Agents Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Neuroprotective Agents Value Chain Analysis
  2. 12.1.1 Neuroprotective Agents Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Neuroprotective Agents Production Mode & Process
  7. 12.2 Neuroprotective Agents Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Neuroprotective Agents Distributors
  10. 12.2.3 Neuroprotective Agents Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst